Astal Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Astal Laboratories	Halder Venture	Balgopal Commercial
Operational Metrics
Financials
5 yr Average ROE	5.65 %	11.11 %	19.17 %
5yr average Equity Multiplier	1.45	5.19	1.21
5yr Average Asset Turnover Ratio	0.4	1.86	0.22
5yr Avg Net Profit Margin	3.54 %	1.35 %	401.47 %
Price to Book	7.83	2.34	5.78
P/E	34.53	71.15	0.0
5yr Avg Cash Conversion Cycle	83.93 Days	115.43 Days	4318.31 Days
Inventory Days	12.25 Days	76.19 Days	1685.56 Days
Days Receivable	123.54 Days	65.32 Days	0.0
Days Payable	125.63 Days	23.45 Days	58.43 Days
5yr Average Interest Coverage Ratio	21.93	3.07	1370.87
5yr Avg ROCE	7.95 %	25.82 %	20.78 %
5yr Avg Operating Profit Margin	4.11 %	4.63 %	-59.92 %
5 yr average Debt to Equity	0.08	2.76	0.01
5yr CAGR Net Profit	289.2 %	29.92 %	n/a
5yr Average Return on Assets	3.24 %	2.34 %	15.89 %
Shareholdings
Promoter Holding	18.19 %	73.84 %	45.43 %
Share Pledged by Promoters	0.0	0.0	0.75 %
Change in Promoter Holding (3 Yrs)	-49.99 %	8.16 %	39.12 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0